Utah Medical Products, Inc. (UTMD)
NASDAQ: UTMD · Real-Time Price · USD
70.94
-0.02 (-0.03%)
Jul 29, 2026, 4:00 PM EDT - Market closed
Utah Medical Products Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 36.11 | 38.52 | 40.9 | 50.22 | 52.28 | 49.05 |
Revenue Growth | -7.00% | -5.83% | -18.56% | -3.94% | 6.58% | 16.30% |
Gross Profit Gross Profit Growth | 20.91 | 22 | 24.14 | 30.04 | 32.2 | 30.92 |
Operating Income Operating Income Growth | 10.27 | 11.4 | 13.59 | 16.78 | 19.79 | 18.88 |
Net Income Net Income Growth | 5.32 | 11.29 | 13.87 | 16.64 | 16.47 | 14.79 |
Earnings Per Share EPS Growth | 3.29 | 3.48 | 3.96 | 4.57 | 4.52 | 4.04 |
EPS Growth | -12.07% | -12.12% | -13.35% | 1.11% | 11.88% | 37.41% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
United States United States Growth | 22.04 | 22.76 | 23.87 | 30.41 | 34.52 | 31.76 |
Europe Europe Growth | - | 7.93 | 8.71 | 8.92 | 7.21 | 7.43 |
Other Other Growth | - | 7.83 | 8.33 | 10.89 | 10.54 | 9.86 |
Total Total Growth | 36.11 | 38.52 | 40.9 | 50.22 | 52.28 | 49.05 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 87.53 | 85.76 | 82.98 | 92.87 | 75.05 | 60.97 |
Total Debt Total Debt Growth | 0.19 | 0.23 | 0.28 | 0.3 | 0.34 | 0.4 |
Net Cash (Debt) Net Cash Growth | 87.33 | 85.53 | 82.69 | 92.57 | 74.71 | 60.58 |
Net Cash Growth | 6.60% | 3.43% | -10.67% | 23.91% | 23.33% | 18.19% |
Net Cash Per Share Net Cash Per Share Growth | 27.35 | 26.40 | 23.61 | 25.45 | 20.51 | 16.55 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 13.34 | 14.69 | 14.83 | 22.28 | 21.15 | 21.2 |
Capital Expenditures CapEx Growth | -0.32 | -0.37 | -0.23 | -0.64 | -0.81 | -0.55 |
Free Cash Flow Free Cash Flow Growth | 13.02 | 14.32 | 14.6 | 21.64 | 20.34 | 20.65 |
Free Cash Flow Growth | -4.45% | -1.92% | -32.53% | 6.41% | -1.52% | 7.13% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 57.90% | 57.12% | 59.03% | 59.81% | 61.58% | 63.03% |
Operating Margin | 28.43% | 29.60% | 33.23% | 33.40% | 37.85% | 38.49% |
Pretax Margin | 35.68% | 36.63% | 41.08% | 40.00% | 39.52% | 38.86% |
Profit Margin | 14.73% | 29.30% | 33.92% | 33.12% | 31.51% | 30.15% |
FCF Margin | 0.00% | 37.18% | 35.70% | 43.09% | 38.90% | 42.10% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 1.240 | 1.225 | 1.205 | 1.185 | 1.165 | 0.855 |
Dividend Per Share Growth | 1.65% | 1.66% | 1.69% | 1.72% | 36.26% | -23.66% |
Dividend Yield | 1.75% | 2.20% | 1.98% | 1.40% | 0.87% | 3.14% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 21.61 | 16.08 | 15.52 | 18.43 | 22.24 | 24.75 |
Forward PE | - | 17.80 | 17.80 | 17.80 | 17.80 | 17.80 |
P/FCF Ratio | 17.34 | 12.45 | 14.04 | 14.12 | 17.93 | 17.70 |
PS Ratio | 6.25 | 4.63 | 5.01 | 6.09 | 6.98 | 7.45 |